Preclinical study of a Kv11.1 potassium channel activator as antineoplastic approach for breast cancer

Daniela F. Fukushiro-Lopes(Loyola University Chicago), Saverio Gentile(Loyola University Chicago)
Oncotarget
December 4, 2017
Cited by 47


Related Papers